At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub
FDA Law Blog
JULY 17, 2024
Importantly, the Hub is intended to establish a new model within FDA, which leverages cross-Agency expertise in providing guidance and conducting reviews for products for rare disease populations. Early Direction for the Rare Disease Innovation Hub The Hub, which will be co-chaired by Drs.
105 
Let's personalize your content